摘要
目的运用文献计量学方法探究近十年急性ST段抬高型心肌梗死研究的现状、热点以及趋势。方法以Web of Science核心合集数据库作为检索对象,利用CiteSpace和Excel软件从国家、机构、期刊、研究热点等方面进行统计分析。结果急性ST段抬高型心肌梗死研究国际文献产出呈现快速增加趋势,中国文献产出尤为迅速。发文量居前的国家依次为美中意,中心性居前的国家是美国、沙特阿拉伯,居前的机构一半是美国机构。高频关键词依次为经皮冠状动脉介入治疗、死亡率、结局、血管成形术、管理、影响、相关性、再灌注、危险、指南等。近两年突现关键词是替格瑞洛、生存率、ST段抬高、心肌标志物、诊断。结论近十年研究热点主要集中在经皮冠状动脉介入治疗、血管成形术、再灌注、替格瑞洛等治疗方法和效果,死亡率、危险因素等流行病学指标,临床管理和临床指南,以及梗死面积、ST段抬高等临床指标。国内外研究热点总体一致,中国处于国际领先地位,但国际合作和影响力有待进一步提高。
Objective To investigate the current situation,hotspots and trends acute ST-segment elevation myocardial infarction(STEMI)over the past 10 years by applied bibliometric method.Methods The core collection database of Web of Science was taken as retrieving object,and searching results were analyzed in aspects of countries,institutions,magazines and research hotspots by using CiteSpace software and Excel software.Results The literature output of STEMI research has been increasing rapidly,especially in China.The most prolific countries were USA,China and Italy.The high centrality countries were USA and Saudi Arabia.Half of the top institutions were in USA.The high frequency keywords were percutaneous coronary intervention(PCI),mortality,outcomes,angioplasty,management,influence,correlation,reperfusion,risk and guideline.The burst keywords in recent 2 y were ticagrelor,survival rate,ST-segment elevation,myocardial biomarkers and diagnosis.Conclusion In resent decade,the research hotspots of STEMI mainly focus on therapies and curative effect including PCI,angioplasty,reperfusion and ticagrelor,epidemiological indexes including mortality and risk factors,clinical management and guideline,and clinical indexes including infarction size and ST-segment elevation.The research hotspots in China are generally consistent with those in other counties,and China is in a leading position in the world,while international cooperation and influence need to be improved.
作者
田芳洁
郭军
陈韬
Tian Fangjie;Guo Jun;Chen Tao(Department of Cardiovascular Medicine,Sixth Medical Center of Chinese PLA General Hospital,Beijing 100048,China;不详)
出处
《中国循证心血管医学杂志》
2022年第5期540-544,553,共6页
Chinese Journal of Evidence-Based Cardiovascular Medicine
作者简介
通讯作者:郭军,E-mail:guojun301@hotmail.com。